Scaffold Repurposing Reveals New Nanomolar Phosphodiesterase Type 5 (PDE5) Inhibitors Based on Pyridopyrazinone Scaffold: Investigation of In Vitro and In Silico Properties

  • Kamelia M. Amin
  • , Ossama M. El-Badry
  • , Doaa E. Abdel Rahman
  • , Magda H. Abdellattif
  • , Mohammed A.S. Abourehab
  • , Mahmoud H. El-Maghrabey
  • , Fahmy G. Elsaid
  • , Mohamed A. El Hamd
  • , Ahmed Elkamhawy
  • , Usama M. Ammar

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Scaffold Repurposing Reveals New Nanomolar Phosphodiesterase Type 5 (PDE5) Inhibitors Based on Pyridopyrazinone Scaffold: Investigation of In Vitro and In Silico Properties'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science